Literature DB >> 19700886

Amalric sign and central retinal artery with lateral posterior ciliary artery occlusion.

Natesh Sribhargava, K Harsha, Savitha Prasad, Bhujang K Shetty.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19700886      PMCID: PMC2804136          DOI: 10.4103/0301-4738.55060

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


× No keyword cloud information.
Dear Editor, Amalric was the first to describe an unusual triangular pigmented disturbance in the fundi of patients with ischemic ocular disorders.[1] The same sign is described in vasculitides like polyarteritis nodosa,[2] giant cell arteritis and Wegener's granulomatosis. We present our experience of managing a patient with “Amalric sign”. A 37-year-old gentleman, a chronic smoker, presented with sudden onset of blurred vision in left eye of three days duration. Best corrected vision in right eye was 20/40 and left eye was counting fingers at half meter. He had a relative afferent pupillary defect (RAPD) in left eye, and retinal edema with an indistinct cherry red spot. There were triangular hypopigmented subretinal lesions extending temporal to the macula [Fig. 1a,1b]. Fundus fluorescein angiography showed delayed arm to retina time, widened watershed zone, choroidal non-perfusion areas, delayed arteriovenous transit time and triangular hyperfluorescent areas corresponding to the hypopigmented patches which densely fluoresced in late phase [Fig. 2,3a, 3b]. Optical coherence tomography showed increased reflectivity and thickness of the inner retina and a corresponding decrease of reflectivity in the outer retinal layers. The retina was thin over the hypopigmented lesions [Fig. 4a, 4b]. Investigations done were normal except for raised triglycerides 700 mg/dL (ref: 40-140), decreased high-density lipoprotein 12 mg/dL (ref: 30-60) levels and elevated serum homocysteine levels 27.47 mcmol/L (ref: 5.90-16.0). Echocardiography was normal. Carotid Doppler showed complete occlusion of left distal internal carotid artery (ICA).
Figure 1a,1b

Pigmentary changes at midperiphery temporal to the macula

Figure 2

Fundus fluorescein angiography depicting delayed arteriovenous transit time and the hyperfluorescent areas at the midperiphery temporal to the macula

Figure 3a and 3b

Late phases of angiography showing the typical triangular hyperfluorescent area

Figure 4a and 4b

Optical coherence tomography (OCT) picture through the fovea (4a), OCT through the hypopigmented lesion at the midperipheral area showing thinning of the retina (4b)

Pigmentary changes at midperiphery temporal to the macula Fundus fluorescein angiography depicting delayed arteriovenous transit time and the hyperfluorescent areas at the midperiphery temporal to the macula Late phases of angiography showing the typical triangular hyperfluorescent area Optical coherence tomography (OCT) picture through the fovea (4a), OCT through the hypopigmented lesion at the midperipheral area showing thinning of the retina (4b) This case of central retinal artery occlusion (CRAO) with lateral posterior ciliary artery (LPCA) and distal ICA occlusion demonstrates the rare finding of triangular sign of Amalric. Amalric postulated that this disturbance was caused by choroidal infarction.[1] Hayreh produced similar lesions in rhesus monkeys by cutting the medial and LPCA. He noted that these lesions occurred at 18–24 h of PCA occlusion, were elongated, subretinal and became depigmented after two to three weeks.[3] They were located in the periphery, with bases toward the equator and apices toward the posterior pole.[4] This is the first photographed case of the triangular sign of Amalric in CRAO and LPCA occlusion due to ICA occlusion in a smoker. The delayed arteriovenous transit time, RAPD suggest CRAO apart from the cherry red spot. The patient did not have any optic disc features of anterior ischemic optic neuropathy. The lacunae were the lack of indocyanin green (ICG) and electrophysiological tests. However, patient did not consent for the same and was lost to follow-up. Amalric sign is a rare clinical finding that indicates choroidal ischemia and may be associated with CRAO.
  4 in total

Review 1.  Posterior ciliary artery circulation in health and disease: the Weisenfeld lecture.

Authors:  Sohan Singh Hayreh
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-03       Impact factor: 4.799

2.  Occlusion of the posterior ciliary artery. II. Chorio-retinal lesions.

Authors:  S S Hayreh; J A Baines
Journal:  Br J Ophthalmol       Date:  1972-10       Impact factor: 4.638

3.  Acute choroidal ischaemia.

Authors:  P Amalric
Journal:  Trans Ophthalmol Soc U K       Date:  1971

4.  Choroidal infarction, anterior ischemic optic neuropathy, and central retinal artery occlusion from polyarteritis nodosa.

Authors:  C T Hsu; J B Kerrison; N R Miller; M F Goldberg
Journal:  Retina       Date:  2001       Impact factor: 4.256

  4 in total
  5 in total

1.  Triamcinolone emboli leading to central retinal artery occlusion: a multimodal imaging study.

Authors:  Nripen Gaur; Pallavi Singh; Rohan Chawla; Brijesh Takkar
Journal:  BMJ Case Rep       Date:  2017-02-22

2.  Hemi-central retinal artery occlusion in young adults.

Authors:  Pukhraj Rishi; Ekta Rishi; Tarun Sharma; Sheshadri Mahajan
Journal:  Indian J Ophthalmol       Date:  2011 Sep-Oct       Impact factor: 1.848

3.  Amalric sign: An augur of ophthalmic artery occlusion.

Authors:  Prathibha Hande; Babi Sinha; Shivani Nayak; Srilakshmi Srinivasan; Jyothi Shetty
Journal:  Indian J Ophthalmol       Date:  2017-10       Impact factor: 1.848

4.  Polycythemia causing posterior segment vascular occlusions.

Authors:  Suganeswari Ganesan; Rajiv Raman; Tarun Sharma
Journal:  Oman J Ophthalmol       Date:  2017 Jan-Apr

5.  Amalric triangular sign in a case of central retinal artery occlusion combined with posterior ciliary artery occlusion - Case report.

Authors:  Soojin Lim; Cheng-Kuo Cheng; Yi-Hsuan Li
Journal:  Am J Ophthalmol Case Rep       Date:  2018-06-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.